Richard Barfield presented at the Proactive One2One virtual investor forum

Richard Barfield, Ergomed’s Chief Financial Officer, had the pleasure to present on Ergomed as a fast-growing global provider of expert, high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information.